Latest Insider Transactions at Incyte Corp (INCY)
This section provides a real-time view of insider transactions for Incyte Corp (INCY). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of INCYTE CORP to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of INCYTE CORP's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 31
2021
|
Edmund Harrigan Director |
BUY
Grant, award, or other acquisition
|
Direct |
253
+4.53%
|
$18,469
$73.4 P/Share
|
|
Dec 31
2021
|
Baker Bros. Advisors LP |
BUY
Grant, award, or other acquisition
|
Indirect |
838
+0.01%
|
-
|
|
Dec 23
2021
|
Wendy L Dixon Director |
SELL
Open market or private sale
|
Direct |
20,000
-53.68%
|
$440,000
$22.05 P/Share
|
|
Dec 23
2021
|
Wendy L Dixon Director |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+34.93%
|
$1,460,000
$73.25 P/Share
|
|
Dec 17
2021
|
Baker Bros. Advisors LP |
BUY
Open market or private purchase
|
Indirect |
1,075,872
+1.71%
|
$77,462,784
$72.84 P/Share
|
|
Dec 16
2021
|
Baker Bros. Advisors LP |
BUY
Open market or private purchase
|
Indirect |
169,315
+0.28%
|
$12,021,365
$71.98 P/Share
|
|
Dec 15
2021
|
Baker Bros. Advisors LP |
BUY
Open market or private purchase
|
Indirect |
350,332
+0.2%
|
$24,172,908
$69.87 P/Share
|
|
Dec 10
2021
|
Dashyant Dhanak EVP & Chief Scientific Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
533
-1.57%
|
$34,645
$65.4 P/Share
|
|
Nov 19
2021
|
Dashyant Dhanak EVP & Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,734
+3.83%
|
-
|
|
Nov 19
2021
|
Barry P Flannelly EVP & General Manager US |
BUY
Grant, award, or other acquisition
|
Direct |
2,734
+2.27%
|
-
|
|
Nov 19
2021
|
Herve Hoppenot Chairman / CEO |
BUY
Grant, award, or other acquisition
|
Direct |
15,506
+2.18%
|
-
|
|
Nov 19
2021
|
Vijay K Iyengar EVP, GMAPPS |
BUY
Grant, award, or other acquisition
|
Direct |
2,734
+4.35%
|
-
|
|
Nov 19
2021
|
Maria E Pasquale EVP & General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
2,734
+3.35%
|
-
|
|
Nov 19
2021
|
Christiana Stamoulis EVP & Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,734
+3.06%
|
-
|
|
Nov 19
2021
|
Steven H Stein EVP & Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,734
+1.28%
|
-
|
|
Nov 19
2021
|
Paula J Swain EVP, Human Resources |
BUY
Grant, award, or other acquisition
|
Direct |
2,734
+2.09%
|
-
|
|
Oct 01
2021
|
Dashyant Dhanak EVP & Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
389
-1.23%
|
$26,452
$68.67 P/Share
|
|
Sep 30
2021
|
Paul J Clancy Director |
BUY
Grant, award, or other acquisition
|
Direct |
321
+4.04%
|
$21,828
$68.78 P/Share
|
|
Sep 30
2021
|
Wendy L Dixon Director |
BUY
Grant, award, or other acquisition
|
Direct |
244
+1.39%
|
$16,592
$68.78 P/Share
|
|
Sep 30
2021
|
Jacqualyn A Fouse Director |
BUY
Grant, award, or other acquisition
|
Direct |
271
+3.3%
|
$18,428
$68.78 P/Share
|
|
Sep 30
2021
|
Edmund Harrigan Director |
BUY
Grant, award, or other acquisition
|
Direct |
237
+4.46%
|
$16,116
$68.78 P/Share
|
|
Sep 30
2021
|
Baker Bros. Advisors LP |
BUY
Grant, award, or other acquisition
|
Indirect |
786
+0.01%
|
-
|
|
Sep 27
2021
|
Otis W Brawley Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,255
+50.0%
|
-
|
|
Sep 24
2021
|
Maria E Pasquale EVP & General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
382
+1.04%
|
$24,830
$65.36 P/Share
|
|
Sep 20
2021
|
Paula J Swain EVP, Human Resources |
BUY
Exercise of conversion of derivative security
|
Direct |
1,356
+2.18%
|
$98,988
$73.21 P/Share
|
|
Sep 01
2021
|
Dashyant Dhanak EVP & Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
388
-1.21%
|
$29,488
$76.71 P/Share
|
|
Aug 02
2021
|
Dashyant Dhanak EVP & Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
389
-1.2%
|
$29,953
$77.49 P/Share
|
|
Jul 29
2021
|
Vijay K Iyengar EVP, GMAPPS |
SELL
Open market or private sale
|
Direct |
4,911
-15.39%
|
$383,058
$78.29 P/Share
|
|
Jul 06
2021
|
Barry P Flannelly EVP & General Manager US |
SELL
Payment of exercise price or tax liability
|
Direct |
273
-0.49%
|
$22,659
$83.34 P/Share
|
|
Jul 06
2021
|
Herve Hoppenot Chairman / CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,562
-0.47%
|
$129,646
$83.34 P/Share
|
|
Jul 06
2021
|
Vijay K Iyengar EVP, GMAPPS |
SELL
Payment of exercise price or tax liability
|
Direct |
401
-1.24%
|
$33,283
$83.34 P/Share
|
|
Jul 06
2021
|
Paula J Swain EVP, Human Resources |
SELL
Payment of exercise price or tax liability
|
Direct |
273
-0.46%
|
$22,659
$83.34 P/Share
|
|
Jul 06
2021
|
Steven H Stein EVP & Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
402
-0.39%
|
$33,366
$83.34 P/Share
|
|
Jul 06
2021
|
Yao Wenqing EVP, Head of Discovery Chem |
SELL
Payment of exercise price or tax liability
|
Direct |
405
-0.41%
|
$33,615
$83.34 P/Share
|
|
Jul 06
2021
|
Paul Trower Principal Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
104
-0.32%
|
$8,632
$83.34 P/Share
|
|
Jul 02
2021
|
Dashyant Dhanak EVP & Chief Scientific Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,573
-4.63%
|
$130,559
$83.58 P/Share
|
|
Jul 02
2021
|
Dashyant Dhanak EVP & Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
7,853
+18.76%
|
-
|
|
Jul 02
2021
|
Barry P Flannelly EVP & General Manager US |
SELL
Payment of exercise price or tax liability
|
Direct |
1,990
-3.42%
|
$165,170
$83.58 P/Share
|
|
Jul 02
2021
|
Barry P Flannelly EVP & General Manager US |
BUY
Grant, award, or other acquisition
|
Direct |
7,853
+11.9%
|
-
|
|
Jul 02
2021
|
Herve Hoppenot Chairman / CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
16,089
-4.63%
|
$1,335,387
$83.58 P/Share
|
|
Jul 02
2021
|
Herve Hoppenot Chairman / CEO |
BUY
Grant, award, or other acquisition
|
Direct |
44,264
+11.3%
|
-
|
|
Jul 02
2021
|
Vijay K Iyengar EVP, GMAPPS |
SELL
Payment of exercise price or tax liability
|
Direct |
1,990
-5.8%
|
$165,170
$83.58 P/Share
|
|
Jul 02
2021
|
Vijay K Iyengar EVP, GMAPPS |
BUY
Grant, award, or other acquisition
|
Direct |
7,853
+18.63%
|
-
|
|
Jul 02
2021
|
Maria E Pasquale EVP & General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
2,241
-5.89%
|
$186,003
$83.58 P/Share
|
|
Jul 02
2021
|
Maria E Pasquale EVP & General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
7,853
+17.11%
|
-
|
|
Jul 02
2021
|
Christiana Stamoulis EVP & Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
516
-1.27%
|
-
|
|
Jul 02
2021
|
Christiana Stamoulis EVP & Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
7,853
+16.15%
|
-
|
|
Jul 02
2021
|
Paula J Swain EVP, Human Resources |
SELL
Payment of exercise price or tax liability
|
Direct |
1,990
-3.22%
|
$165,170
$83.58 P/Share
|
|
Jul 02
2021
|
Paula J Swain EVP, Human Resources |
BUY
Grant, award, or other acquisition
|
Direct |
7,853
+11.26%
|
-
|
|
Jul 02
2021
|
Steven H Stein EVP & Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,953
-2.8%
|
$245,099
$83.58 P/Share
|